Search for: "NOVO NORDISK PHARMACEUTICALS, INC."
Results 41 - 60
of 88
Sort by Relevance
|
Sort by Date
30 Nov 2011, 8:26 am
Novo Nordisk. [read post]
21 Nov 2011, 5:35 pm
Novo Nordisk A/S, Docket No. [read post]
24 Aug 2011, 12:33 am
The lobbying push for a PTE (FDA Law Blog) US: Generics fees: A fantastic opportunity (profitability through simplicity) USPTO announces agenda for next BCP customer partnership meeting (Patent Docs) US: GOP candidates unified in opposition to embryonic cell research (Patent Docs) US: District Court Massachusetts: Method of detecting fetal down syndrome passes muster under Bilski‘s machine-or-transformation test: PerkinElmer, Inc., et. al. v. [read post]
22 Aug 2011, 2:00 am
Novo Nordisk Pharms. [read post]
22 Aug 2011, 2:00 am
Novo Nordisk Pharms. [read post]
27 Jul 2011, 4:06 pm
The panel invited a response from Plaintiffs-Appellants Novo Nordisk A/S and Novo Nordisk, Inc. [read post]
8 Jul 2011, 11:04 am
IMS Health Inc., ___ U.S. ___, 2011 WL 2472796, at *8 (U.S. [read post]
6 Jul 2011, 2:21 am
Biopet Vet Lab, Inc., et. al. [read post]
3 Jul 2011, 11:08 pm
Hyatt; Caraco Pharmaceutical Laboratories, Ltd. v. [read post]
29 Jun 2011, 7:19 am
Novo Nordisk A/S , U.S., No. 10-844, review granted 6/26/11 ). [read post]
29 Jun 2011, 5:59 am
Novo Nordisk A/S is a case involving a particular aspect of the Hatch-Waxman Act as pertaining to pharmaceutical approval. [read post]
29 Jun 2011, 3:34 am
Sagent Pharmaceuticals, Inc. et al. [read post]
27 Jun 2011, 8:41 am
Amicus brief of Mylan Pharmaceuticals, Inc. [read post]
24 Jun 2011, 3:25 pm
Novo Nordisk A/SDocket: 10-844Issue(s): Whether the counterclaim provision of the Hatch-Waxman Act applies when (1) there is “an approved method of using the drug” that “the patent does not claim,” and (2) the brand submits “patent information” to the FDA that misstates the patent's scope, requiring “correct[ion]. [read post]
10 Jun 2011, 7:11 am
According to DOJ’s press release: Novo Nordisk Inc., a Danish pharmaceutical manufacturer, has agreed to pay $25 million to resolve its civil liability arising from the illegal promotion of its hemostasis management drug, NovoSeven, the Justice Department announced today. [read post]
27 May 2011, 8:56 am
Novo Nordisk A/S . [read post]
24 Mar 2011, 12:53 pm
Rodriguez Title: Caraco Pharmaceutical Laboratories, Ltd. v. [read post]
29 Dec 2010, 2:57 am
Ferring Pharmaceuticals, Inc et al. [read post]
28 Dec 2010, 10:58 am
District Court for the Eastern District of Michigan (Southern Division) ruled and issued an Order and Injunction requiring Novo Nordisk, Inc. [read post]
8 Dec 2010, 2:20 am
– Nova Biomedical fight for survival following patent threats from Abbott, Roche, Medtronic (IP Directions) Pathogens and the Nagoya Protocol of the Convention on Biological Diversity (PatentlyBIOtech) Australia: Federal Court punishes CSL for amendment delay: CSL Limited v Novo Nordisk Pharmaceuticals Pty Ltd (Patentology) Australia: AusBiotech, legal academics and ARDR weigh in on gene patent debate (Patentology) Australia: Gene patent amendment bill introduced (IP… [read post]
